Contract 70RDAD21D00000003
Virant Diagnostics, Inc · Department Of Homeland Security · November 6, 2020
Virant Diagnostics, Inc was awarded a federal contract by Department Of Homeland Security (Office Of Procurement Operations) on November 6, 2020 for an undisclosed amount of work in in-vitro diagnostic substance manufacturing. It was awarded under full and open competition. The contract has been modified 13 times since the base award It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. The most recent modification was on October 11, 2024. If all options are exercised, the contract could reach $2.00 billion.
Contract details
- PIID
- 70RDAD21D00000003
- Award type
- —
- Pricing
- Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- First action
- November 6, 2020
- Latest action
- October 11, 2024
Description
THE PURPOSE OF THIS MODIFICATION TO THE IDIQ CONTRACT IS TO EXERCISE OPTION PERIOD FOUR.
Modification timeline
-
October 11, 2024Mod P00013$0
-
October 12, 2023Mod P00012THE PURPOSE OF THIS MODIFICATION TO THE IDIQ CONTRACT IS TO EXERCISE OPTION PERIOD THREE.$0
-
July 13, 2023Mod P00011THE PURPOSE OF THIS MODIFICATION TO THE IDIQ CONTRACT IS TO UPDATE THE FOOD AND DRUG ADMINISTRATION (FDA) EMERGENCY USE AUTHORIZATION (EUA) LANGUAGE WITHIN THE$0
-
May 24, 2023Mod P00010THE PURPOSE OF THIS MODIFICATION TO THE IDIQ CONTRACT IS TO CHANGE THE FREQUENCY OF THE TRANSACTIONAL DATA REPORT FROM MONTHLY TO QUARTERLY.$0
-
January 17, 2023Mod P00009THE PURPOSE OF THIS MODIFICATION TO THE IDIQ CONTRACT IS TO UPDATE THE VENDOR POINT OF CONTACT.$0
-
October 6, 2022Mod P00008THE PURPOSE OF THIS MODIFICATION TO THE IDIQ CONTRACT IS TO EXERCISE OPTION PERIOD TWO IN ACCORDANCE WITH FAR 52.218-9, OPTION TO EXTEND THE TERM OF THE CONTRAC$0
-
February 18, 2022Mod P00007THE PURPOSE OF THIS MODIFICATION TO THE IDIQ CONTRACT IS TO CHANGE THE NAME OF VIRANT DIAGNOSTICS, LLC TO VIRANT DIAGNOSTICS, INC. IN ACCORDANCE WITH FAR 42.120$0
-
November 2, 2021Mod P00006EO14042 THE PURPOSE OF THIS MODIFICATION IS TO INCORPORATE FAR 52.223-99 ENSURING ADEQUATE COVID-19 SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS$0
-
October 7, 2021Mod P00005THE PURPOSE OF THIS MODIFICATION TO THE IDIQ CONTRACT IS TO EXERCISE OPTION PERIOD ONE$0
-
September 10, 2021Mod P00004THE PURPOSE OF THIS MODIFICATION TO THE IDIQ CONTRACT IS TO UPDATE FUNCTIONAL CATEGORY (FC) 2 AND FC3 TESTING SOLUTIONS.$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Parsons Government Services Inc. | Department Of Homeland Security | December 12, 2025 | $1.90M |
| Parsons Government Services Inc. | Department Of Homeland Security | August 13, 2025 | $22.98M |
| Federal Resources Supply Company | Department Of Homeland Security | September 12, 2024 | $1.32M |
| Parsons Government Services Inc. | Department Of Homeland Security | September 30, 2021 | $267 |
| Federal Resources Supply Company | Department Of Homeland Security | September 16, 2021 | $117.0K |
| Mriglobal | Department Of Homeland Security | September 13, 2021 | $0 |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 70RDAD21D00000003?
Contract 70RDAD21D00000003 is a federal contract awarded to Virant Diagnostics, Inc by Department Of Homeland Security on November 6, 2020 for an undisclosed amount of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 13 times since the base award.
Who won contract 70RDAD21D00000003?
Virant Diagnostics, Inc won contract 70RDAD21D00000003 from Department Of Homeland Security.
How much is contract 70RDAD21D00000003 worth?
Contract 70RDAD21D00000003 has obligated $0 to date but carries a potential ceiling of $2.00 billion if fully funded and all options are exercised.